Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is often characterized by a
life-threatening interstitial pneumonia requiring hospitalization. The aim of this retrospective …

Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Objectives As early prediction of severe illness and death for patients with coronavirus
disease 2019 (COVID-19) is important, we aim to explore the clinical value of laboratory …

Background: The central role of inflammatory progression in the development of
Coronavirus disease 2019 (COVID-19), especially in severe cases, is indisputable …

Objectives Studies reported associations of inflammatory markers with the severity of COVID-
19, but conclusions were inconsistent. We aimed to provide an overview of the association …

It remains important to investigate the changing and impact of routine blood values (RBVs)
in order to predict mortality and follow an appropriate treatment in COVID-19 patients. In the …

Aim: The aim of the study is to study the utility of various inflammatory markers in predicting
outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia …

Abstract Background Coronavirus disease-2019 (COVID-19) is a global pandemic and high
mortality rate among severe or critical COVID-19 is linked with SARS-CoV-2 infection …

Background In pandemic situations, it is essential that the limited resources are used
judiciously to achieve most benefits. Prediction of the disease severity at the earliest will …

(1) Background: Since its discovery, COVID-19 has caused more than 256 million cases,
with a cumulative death toll of more than 5.1 million, worldwide. Early identification of …